Argent Biopharma (AU:RGT) has released an update.
Argent BioPharma Ltd., a biopharmaceutical company specializing in innovative drug development, especially for CNS and immunology treatments, has announced the dispatch of General Meeting documentation to shareholders. The meeting is scheduled for October 1, 2024, in Subiaco, Western Australia. Shareholders are directed to the company’s website for further details.
For further insights into AU:RGT stock, check out TipRanks’ Stock Analysis page.
